ulyanaimiiurebor.blogspot.com
The company reported $92.34 million in revenue for the quartetr endingApril 30, up 2 percent from the same perios last year. It earned $11 million in net income, or 33 cents per diluted during thesecond quarter, compared with $9.2 million, or 28 centxs per diluted share, during the second quarter of last Analysts polled by expected the company to earn 29 cents per share and $89 millioj in revenue. Martek (NASDAQ: MATK) sells nutritional oils derivede from algae that are used ininfanyt formula, dietary supplements and food products such as yogurg and juice. Sales of its nutritional supplementas to the nursing market rose to arecord $9.
8 But the company warned that its infantf formula sales in the third and fourth quarteres could drop as retailers trim theird inventories of the The company anticipates that infant formula revenude will grow in fiscal 2010 as a result of strong demandx for infant formula products containing its nutritional oils DHA and ARA. The Omega-w fatty acids are believed to play an important role in brainb andeye development. study that could show that Martek’se DHA can slow the progressionof Alzheimer’as disease.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment